Rituximab and Ocrelizumab in Serum With Multiple Sclerosis

Clinical trial NCT06663111 · RECRUITING

Trial details

NCT number: NCT06663111
Sponsor: Haukeland University Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2021-03-15
Primary completion: 2025-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.